J. Stern & Co. LLP Dexcom Inc Transaction History
J. Stern & Co. LLP
- $1.32 Trillion
- Q3 2025
A detailed history of J. Stern & Co. LLP transactions in Dexcom Inc stock. As of the latest transaction made, J. Stern & Co. LLP holds 72,332 shares of DXCM stock, worth $4.2 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
72,332
Previous 40,048
80.61%
Holding current value
$4.2 Million
Previous $3.38 Billion
43.81%
% of portfolio
0.37%
Previous 0.29%
Shares
8 transactions
Others Institutions Holding DXCM
# of Institutions
1,087Shares Held
442MCall Options Held
6.78MPut Options Held
7.25M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct69.2MShares$4.01 Billion2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...